We look after a health that guarantees the cure through programs and interest groups.
Patient associations are essential to defend the interests of those affected by Alpha-1 Antitrypsin Deficiency, and their families.
Through these partnerships, we want to ensure access to care available to patients, including intravenous AATD replacement therapy.
This treatment is aimed at patients with COPD, due to severe Alpha-1 Antitrypsin deficiency.
The Alpha-1 Center in Granada has established contacts with Associations of Patients with AATD; It also participates in joint activities with them to give them support and resolve their doubts.
Likewise, we support the development of ANTAE-Alfacare patient support programs.